Qunol's magnesium glycinate binds the mineral to an amino acid for better absorption than standard magnesium oxide, without the GI side effects. 300mg per serving, 2 tablets daily, 60–150 count bottles. Supports relaxation, muscle health, and sleep.
Magnesium deficiency is well-established as harmful, and supplementation improves multiple outcomes in deficient populations. Observational and RCT evidence supports magnesium for sleep quality, anxiety, and muscle function. Magnesium glycinate specifically has not been directly compared to other forms in large RCTs, but the underlying magnesium effect is robust. The glycine chelation is theoretically sound for absorption and GI tolerance, though head-to-head trials are limited.
Magnesium glycinate is a chelated form of magnesium bound to glycine, an amino acid. Magnesium acts as a cofactor in over 300 enzymatic reactions, including ATP synthesis, protein synthesis, and neuromuscular function. Glycine itself may enhance absorption and has mild GABAergic activity. The combination is marketed for better bioavailability and gentler gastrointestinal tolerability compared to other magnesium salts.
EOD publishes opinions and summaries of research about supplements, services, and protocols. It is not medical advice. Consult a qualified healthcare provider before changing your supplement, exercise, sleep, or medication regimen.
Some outbound links on EOD are affiliate links. If you buy through them we may earn a small commission, at no extra cost to you. It never influences what we publish or how it's ranked. Full disclosure.
EOD · 123 Placeholder Street, New York, NY 10001
May be an affiliate link.
Observational
“OBJECTIVE/BACKGROUND: Sleep problems challenge overall wellbeing.”
“PURPOSE: To assess the effects of magnesium bisglycinate supplementation on insomnia symptoms in healthy adults reporting poor sleep quality.”
“OBJECTIVES: Diabetes mellitus is a metabolic condition with hyperglycemia.”
“OBJECTIVES: The therapeutic use of nutrient-based 'nutraceuticals' and plant-based 'phytoceuticals' for the treatment of mental disorders is common; however, despite recent research progress, there have not been any updated global clinical ”
Most RCT evidence focuses on magnesium broadly, not the glycinate form specifically. Bioavailability claims for glycinate versus other chelated or salt forms lack definitive human comparative data. Efficacy depends on baseline magnesium status; supplementation in replete individuals shows minimal benefit. Doses vary widely across studies, and optimal dosing for specific outcomes remains unclear. Some trials are small or industry-sponsored.
0 comments
Join the conversation. Members can comment, verify, and save finds. Free.
Sign in to comment